Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
Press releases
- US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma
- ViiV Healthcare submits regulatory application to the European Medicines Agency for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available
- Deborah Waterhouse, CEO of ViiV Healthcare, to join GSK Corporate Executive Team (CET)
GSK US Twitter
-
GSKUS @GSKUS
We’re proud to have received 100% on @HRC 's Corporate Equality Index for the 14th consecutive year. At GSK, we strive to create a safe environment where everyone can bring their best and most authentic selves to work. #CEI2020 #LGBTQ See full index 👉gsk.to/36jPDNToT
about 3 days ago -
GSKUS @GSKUS
#NEWS The @US_FDA has granted priority review of our application for a new treatment that may help patients with relapsed or refractory multiple #myeloma Read more: gsk.to/37gGyq3 #bloodcancer
about 3 days ago
-
GSK in the US
GSK is dedicated to helping grow the US economy and supporting communities by creating high-quality jobs in areas like R&D, manufacturing, and sales.
-
Pharmaceuticals
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
-
Vaccines
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
-
Consumer Healthcare
Our Consumer Healthcare business develops and markets consumer preferred and expert recommended brands in the Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories.
